Effects of Lipids on Gastric Emptying, Satiety Hormones, and Appetite in Severe Overweight

Sponsor

Hvidovre University Hospital (Other)

Overall Status

Completed

CT.gov ID

NCT01681459

Collaborator

(none)

Enrollment

Location

Duration (Months)

0.6

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

In lean subjects, free fatty acid (FFA) promotes gut hormone release, delays gastric emptying, and reduces appetite and energy intake more than an isocaloric load of triglyceride (TG). In obesity, the gastrointestinal sensitivity to food components may be reduced. In this study, the investigators compare the effects of the FFA oleic acid and the TG olive oil on gut hormone secretion, gastric emptying, appetite sensation, and subsequent energy intake in lean and severely obese subjects.

Condition or Disease	Intervention/Treatment	Phase
Effects of Lipids on Gastric Emptying Effects of Lipids on Satiety Hormones Effects of Lipids on Appetite

Detailed Description

Nutritional lipid within the lumen of small intestine causes a range of physiological responses that suppress appetite and reduce energy intake. Thus, intestinal fat promotes the release of gastrointestinal hormones such as cholecystokinin (CCK), peptide-YY (PYY) and glucagon-like peptide-1 (GLP-1) that modulate gastrointestinal motility and are important for appetite regulation and food consumption.

The effect of ingested fat on gut hormone secretion is highly dependent on the lipolysis of triglycerides (TGs) into free fatty acids (FFAs). It has been demonstrated that adding a lipase inhibitor (tetrahydrolipstatin) to a pure fat meal accelerates gastric emptying and reduces CCK release. Furthermore, administration of tetrahydrolipstatin with an intraduodenal infusion of TG attenuates gastric relaxation and antro-pyloro-duodenal motility and reduces the release of CCK, PYY, and GLP-1 compared to TG alone. Finally, intragastric administration of FFA delays gastric emptying and augments the release of CCK and PYY compared to an isocaloric administration of TG. Hence, the presence of FFAs more than TGs within the small intestine seem to play a pivotal role in the regulation of appetite and energy intake.

Whereas acute intake of FFA represents a potent stimulus for suppression of appetite and energy intake, epidemiological evidence relates long-term high dietary fat intake with obesity and it is known that obese individuals prefer food with high fat content. The mechanisms behind this paradox remain unclear. However, sustained high fat-diet may change gastromotor responses and gut hormonal release to a dietary load of lipids. Moreover intraduodenal sensitivity to FFA (oleic acid) was recently reported to be reduced in obese subjects. The reduced appetite and energy intake after FFAs compared to TGs may, therefore, not apply to obese subjects.

The aims of this study are to evaluate gastric emptying, gut hormone secretion, appetite sensation, and energy intake after isocaloric gastric administration of FFA (oleic acid) and TG (olive oil) in lean and severely obese subjects.

Study Design

Study Type:

Observational

Actual Enrollment :

20 participants

Observational Model:

Case-Control

Time Perspective:

Prospective

Official Title:

Effects of Lipids on Gastric Emptying, Satiety Hormones, and Appetite in Severe Overweight

Study Start Date :

Jan 1, 2012

Actual Primary Completion Date :

Dec 1, 2014

Actual Study Completion Date :

Jan 1, 2015

Outcome Measures

Primary Outcome Measures

Eligibility Criteria

Criteria

Ages Eligible for Study:

25 Years to 65 Years

Sexes Eligible for Study:

Male

Accepts Healthy Volunteers:

Yes

Inclusion Criteria:

Lean subjects: BMI 20-25
Severely obese subjects: BMI > 50

Exclusion Criteria:

-Gastrointestinal symptoms

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Hvidovre Hospital	Hvidovre		Denmark	DK-2650

Sponsors and Collaborators

Hvidovre University Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

Responsible Party:

Jan Lysgaard Madsen, Chief Physician, MD, DMSci, Hvidovre University Hospital

ClinicalTrials.gov Identifier:

NCT01681459

Other Study ID Numbers:

H-4-2011-060

First Posted:

Sep 10, 2012

Last Update Posted:

Feb 19, 2016

Last Verified:

Feb 1, 2016

Keywords provided by Jan Lysgaard Madsen, Chief Physician, MD, DMSci, Hvidovre University Hospital

Additional relevant MeSH terms:

Overweight

Study Results

No Results Posted as of Feb 19, 2016